- Report
- January 2023
- 145 Pages
India
From €3721EUR$4,175USD£3,269GBP
- Report
- February 2022
- 210 Pages
Global
From €3900EUR$4,375USD£3,426GBP
- Report
- July 2024
- 87 Pages
Europe
From €1961EUR$2,200USD£1,723GBP
- Report
- April 2024
- 125 Pages
Europe
From €1961EUR$2,200USD£1,723GBP
- Report
- April 2024
- 115 Pages
United States
From €1604EUR$1,800USD£1,409GBP
- Report
- August 2023
- 313 Pages
Global
From €3744EUR$4,200USD£3,288GBP
- Report
- March 2023
- 327 Pages
Global
From €3744EUR$4,200USD£3,288GBP
- Report
- March 2023
- 165 Pages
United States
From €3120EUR$3,500USD£2,740GBP
- Report
- February 2023
- 266 Pages
Global
From €3744EUR$4,200USD£3,288GBP
- Report
- February 2023
- 402 Pages
Global
From €3744EUR$4,200USD£3,288GBP
- Report
- July 2022
- 274 Pages
Global
From €3120EUR$3,500USD£2,740GBP
- Report
- June 2022
- 327 Pages
Global
From €3120EUR$3,500USD£2,740GBP
- Report
- June 2022
- 342 Pages
Global
From €3120EUR$3,500USD£2,740GBP
- Report
- June 2022
- 358 Pages
Global
From €3120EUR$3,500USD£2,740GBP
- Report
- June 2022
- 294 Pages
Global
From €3120EUR$3,500USD£2,740GBP
- Report
- November 2020
- 274 Pages
Global
From €3120EUR$3,500USD£2,740GBP
- Report
- September 2024
- 128 Pages
Europe
From €4145EUR$4,650USD£3,641GBP
- Report
- June 2024
- 132 Pages
Global
From €4145EUR$4,650USD£3,641GBP
- Report
- June 2024
- 136 Pages
Global
From €4145EUR$4,650USD£3,641GBP
- Report
- December 2023
- 192 Pages
Global
From €4145EUR$4,650USD£3,641GBP

The Biotechnology market has been affected by the pandemic in a variety of ways. Companies in the sector have had to adjust their operations to meet the demands of the new environment. Many have shifted their focus to developing treatments and vaccines for the virus, while others have had to pivot their operations to meet the needs of the changing market. Companies have also had to adjust their supply chains to ensure the safety of their products and services.
The pandemic has also had an impact on the financial performance of biotechnology companies. Many have seen their stock prices decline due to the uncertainty of the market. Additionally, the pandemic has caused a decrease in research and development spending, as well as a decrease in venture capital investments.
Notable companies in the biotechnology market include Gilead Sciences, Moderna, Regeneron Pharmaceuticals, and Novavax. These companies have all been involved in the development of treatments and vaccines for the virus. Additionally, they have all seen their stock prices increase due to the pandemic. Show Less Read more